The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients
Open Access
- 9 May 2006
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 94 (11), 1703-1709
- https://doi.org/10.1038/sj.bjc.6603154
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Absence of HER4 Expression Predicts Recurrence of Ductal Carcinoma In situ of the BreastClinical Cancer Research, 2005
- HER-2 Amplification, HER-1 Expression, and Tamoxifen Response in Estrogen Receptor-Positive Metastatic Breast CancerClinical Cancer Research, 2004
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 2004
- Nup88 mRNA overexpression is associated with high aggressiveness of breast cancerInternational Journal of Cancer, 2004
- Expression of the HER1–4 family of receptor tyrosine kinases in breast cancerThe Journal of Pathology, 2003
- HER2 overexpression in muscle‐invasive urothelial carcinoma of the bladder: Prognostic implicationsInternational Journal of Cancer, 2002
- HER4 Mediates Ligand-Dependent Antiproliferative and Differentiation Responses in Human Breast Cancer CellsMolecular and Cellular Biology, 2001
- NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 CellsJournal of Biological Chemistry, 1996
- C-ERBB-2 in Bladder Cancer: Molecular Biology, Correlation with Epidermal Growth Factor Receptors and Prognostic ValueJournal of Urology, 1996